OakChart

Vertex Pharmaceuticals Inc

VRTXHealthcare·Biotechnology·USA·Large·NASD·Nov 11 • 10:48 AM ET

537.98-9.91 (-1.81%)
2026-11-11 16:48 CET
Market cap
138,910.93 USD m
Revenue, TTM
13,022.60 USD m
Net income, TTM
3,975.90 USD m
Free cash flow, TTM
3,202.30 USD m
EPS diluted, TTM
15.55
P/E
34.61
Compare

Price

VRTX against its 20, 50 and 200-day averages
2050200miss
450.00500.00550.004.3M8.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VRTXclose 537.9920-day 531.7550-day 522.86200-day 482.66537.9952w high52w low

5.4% under the 52-week high of 568.67 on 2 Nov 2026. 52-week low 412.27 on 5 May 2026. Last 15 sessions, 11.7% high to low

Profile

VRTX
52-week range, 80% of the way up
412.27568.67

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

IndexNDX, S&P 500, RUI
Employees6400
IPOJul 24, 1991
Beta0.29
ATR, 14d16.53
Rel volume0.66
Short float1.90%
Insider own0.23%
Inst own98.36%

Snapshot

6 groups

Valuation

IndexNDX, S&P 500, RUI
Market Cap136.40B
Enterprise Value136.57B
Income3.98B
Sales13.02B
Book/sh82.47
Cash/sh24.90
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees6400
IPOJul 24, 1991

Ratios

P/E34.61
Forward P/E26.75
PEG2.80
P/S10.47
P/B6.52
P/C21.61
P/FCF42.59
EV/EBITDA28.54
EV/Sales10.49
Quick Ratio1.89
Current Ratio2.34
Debt/Eq0.31
LT Debt/Eq0.26
Option/ShortYes / Yes

Earnings

EPS (ttm)15.55
EPS next Y20.11
EPS next Q4.20
EPS this Y-1.12%
EPS next Y10.56%
EPS next 5Y9.54%
EPS past 3/5Y6.12% 8.28%
Sales past 3/5Y11.34% 14.23%
EPS Y/Y TTM9.37%
Sales Y/Y TTM10.97%
EPS Q/Q-39.08%
Sales Q/Q10.39%
EarningsNov 02 AMC
EPS/Sales Surpr.-1.19% 0.62%

Ownership

Insider Own0.23%
Insider Trans-5.56%
Inst Own98.36%
Inst Trans0.42%
ROA13.81%
ROE20.80%
ROIC15.07%
Gross Margin85.61%
Oper. Margin34.94%
Profit Margin30.53%
SMA201.17%
SMA502.89%
SMA20011.46%
Trades-

Technical

Shs Outstand253.52M
Shs Float252.96M
Short Float1.90%
Short Ratio3.88
Short Interest4.81M
52W High568.67 -5.40%
52W Low412.27 30.49%
Volatility3.16% 3.20%
ATR (14)16.53
RSI (14)53.00
Beta0.29
Rel Volume0.66
Avg Volume1.24M
Volume195,851

Performance

Perf Week-2.01%
Perf Month10.87%
Perf Quarter4.17%
Perf Half Y18.74%
Perf YTD18.67%
Perf Year25.34%
Perf 3Y43.98%
Perf 5Y189.44%
Perf 10Y484.77%
Recom1.57
Target Price598.52
Prev Close547.89
Price537.98
Change %-1.81%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 21, 2026InitiatedLLeerink PartnersOutperform$594+10.4%
Sep 02, 2026ResumedMMorgan StanleyOverweight$665+23.6%
May 27, 2026ResumedTTruistBuy$542+0.7%
Mar 18, 2026UpgradeMMaxim GroupHold → Buy$575+6.9%
Mar 10, 2026ReiteratedOOppenheimerOutperform$540 → $600+11.5%
Mar 10, 2026InitiatedJJefferiesBuy$580+7.8%
Feb 13, 2026UpgradeOOppenheimerPerform → Outperform$540+0.4%
Jan 28, 2026ResumedBBarclaysOverweight$606+12.6%
Jan 22, 2026UpgradeRRBC Capital MktsSector Perform → Outperform$546+1.5%
Jan 12, 2026UpgradeBBernsteinMkt Perform → Outperform

Peers

Mkt cap
TickerCompanyMkt cap
REGNRegeneron Pharmaceuticals Inc94.30B
ALNYAlnylam Pharmaceuticals Inc20.81B
ARGXArgen X SE ADR60.92B
BMRNBiomarin Pharmaceutical Inc11.09B
GILDGilead Sciences Inc210.51B
AMGNAMGEN Inc249.73B
MAZEMaze Therapeutics Inc2.00B
BIIBBiogen Inc37.10B
ABBVAbbvie Inc513.19B
MRKMerck & Co Inc359.02B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kewalramani ReshmaCEO & PresidentNov 06 '26Sale531.5311,8666,307,13586,471Nov 10 04:20 PM
Kewalramani ReshmaOfficerNov 06 '26Proposed Sale531.5311,8666,307,135Nov 06 10:29 AM
Bruce I. SachsDirectorAug 27 '26Proposed Sale547.551,210662,536Aug 27 04:46 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Jul 02 '26Sale524.991,500787,48545,321Jul 07 04:15 PM
McKechnie DuncanEVP, Chief Commercial OfficerJul 02 '26Sale519.001,541799,77911,001Jul 07 04:08 PM
Liu JoyEVP and Chief Legal OfficerJul 01 '26Sale502.71828416,24419,131Jul 06 04:13 PM
Tatsis OuraniaOfficerJul 02 '26Proposed Sale524.991,500787,485Jul 02 04:30 PM
McKechnie DuncanOfficerJul 02 '26Proposed Sale519.001,541799,779Jul 02 02:16 PM
Liu JoyOfficerJul 01 '26Proposed Sale502.71828416,244Jul 01 01:00 PM
Bozic CarmenEVP and CMOJun 26 '26Sale482.50596287,57015,337Jun 30 04:09 PM
Bozic CarmenOfficerJun 26 '26Proposed Sale482.50596287,570Jun 26 09:54 AM
Bozic CarmenEVP and CMOJun 18 '26Sale462.171,020471,41315,933Jun 23 04:08 PM
Bozic CarmenOfficerJun 18 '26Proposed Sale462.171,020471,413Jun 18 11:33 AM
Bozic CarmenEVP and CMOJun 15 '26Sale450.004,0621,827,90016,953Jun 17 04:12 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
QQQInvesco QQQ Trust Series 1AUM: 463.98B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VUGVanguard Morningstar Growth ETFAUM: 217.67B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
IBBiShares Biotechnology ETFAUM: 11.36B
QQQMInvesco NASDAQ 100 ETFAUM: 106.59B
CGGRCapital Group Growth ETFAUM: 25.66B

News

latest 14 of 206
  • Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment (PR Newswire)
  • Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story (PR Newswire)
  • Vertex to Participate in Upcoming Investor Conferences (Business Wire)
  • Vertex Pharmaceuticals Thrives on Higher Sales and Guidance (FX Empire)
  • Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It. (The Wall Street Journal)
  • Loading…
  • Vertex Pharmaceuticals earnings analysis: questions answered and next catalysts (Investing.com)
  • Vertex, ahead of FDA decision, calms fears surrounding kidney drug (BioPharma Dive)
  • Vertex: Q3 Earnings Snapshot (Associated Press)
  • Vertex Misses On EPS As Crinetics And Launch Spending Outpace A Revenue Beat, With CF Growth Cooling Ahead Of Povetacicept Decision (Earnings Whispers)
  • Vertex Continues Its Buy-Zone Run After Hiking 2026 Sales Guidance (Investor's Business Daily)
  • Vertex Reports Third Quarter 2026 Financial Results (Business Wire)
  • Stocktwits Pharma Pulse: Biotech Beats The Broader Market Novo, Pfizer And Moderna Earnings Up Next (Stocktwits)
  • BofA Names this Drugmaker a Top Pick on Promising Kidney Drug Data (Investing.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-024.7604.8172.5603,4413,41921
2026Q22026-08-034.7304.7414.3103,3343,23124
2026Q12026-05-044.4704.2434.0242,9872,99424
2025Q42026-02-125.0305.1114.6513,1903,18425
2025Q32025-11-034.8004.5734.2043,0763,06023
2025Q22025-08-044.5204.2883.9902,9442,90624
2025Q12025-05-054.0604.2452.4912,7702,86222
2024Q42025-02-103.9804.0163.5052,9122,78425
2024Q32024-11-044.3804.0784.0052,7722,68528
2024Q22024-08-01-12.830-11.626-13.9232,6462,66416
2024Q12024-05-064.7604.0734.2112,6912,58125
2023Q42024-02-054.2004.0673.7132,5182,51326
2023Q32023-11-064.0803.9343.9732,4842,50127
2023Q22023-08-013.8903.8593.5172,4932,42124
2023Q12023-05-013.0503.0132.6882,3752,33621
2022Q42023-02-073.7603.5313.1462,3032,30523

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY5.3304.8354.5154,0073,763
2020FY10.32010.39310.2956,2036,161
2021FY13.02012.9599.0127,5737,502
2022FY14.88014.60112.8218,9318,933
2023FY15.23015.03313.8959,8699,863
2024FY0.4200.456-2.07711,02010,890
2025FY18.40018.47815.32011,97111,985
2026FY-18.194--13,255
2027FY-20.115--14,718
2028FY-24.183--16,583
2029FY-29.532--18,733
2030FY-33.792--20,765

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06267103,5003,4153,598
2026Q4S2026-11-04266103,4993,4153,598
2026Q4S2026-11-03266103,4993,4153,598
2026Q4S2026-11-0226323,5153,4433,615
2026Q4S2026-10-2926323,5153,4433,615
2026Q4S2026-10-2326323,5143,4433,609
2026Q4S2026-10-2126413,5153,4433,609
2026Q4S2026-10-2026523,5153,4433,609
2026Q4S2026-10-1826523,5143,4433,609
2026Q4S2026-10-15261163,5143,4433,609
2026Q4S2026-10-14261163,5143,4433,609
2026Q4S2026-10-12261163,5143,4433,609
2026Q4S2026-10-09261163,5133,4433,609
2026Q4S2026-10-08261163,5123,4433,609

Estimate history

EPS, annual1.048.094.51510.2959.01212.82113.895-2.07715.32315.5458
Period201720182019202020212022202320242025TTM
EPS, quarterly4.0053.5052.4913.994.2044.6514.0244.312.561
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2488.6523048.8494130.2756209.3977604.48748.2983910984.412074.613022.6
Period201720182019202020212022202320242025TTM
Sales, quarterly27752887.52746.129863115.43227.13012.43344.13439
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual253.253255.172258.993259.89254.479257.012257.695256.94253.991253.523
Period201720182019202020212022202320242025MRQ
Shares, quarterly257.74256.94256.968256.293253.951253.991254.164253.348253.523
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue13,022.6012,074.6010,984.409,839.008,748.207,604.406,209.404,130.273,048.85
Cost of Goods Sold Incl. D&A1,874.101,807.101,530.501,262.201,080.30904.20736.30547.76409.54
Gross Profit11,148.5010,267.509,453.908,576.807,667.906,700.205,473.103,582.522,639.31
Selling, General and Administrative Excl. Other6,597.805,506.805,094.604,299.503,485.003,891.202,599.992,413.041,974.09
Research and Development4,249.703,753.703,630.303,162.902,540.303,051.101,829.541,754.541,416.48
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income4,550.704,760.704,359.304,277.304,182.902,809.002,873.101,169.48665.22
Interest Expense-13.3030.6044.1054.8061.5058.1558.5034.12
Unusual Expense179.90560.104,625.70478.60230.00-1.60-145.18-123.2028.19
Net Income Before Taxes4,759.104,643.20248.504,379.804,232.402,730.403,116.801,394.92600.24
Income Taxes783.20690.00784.10760.20910.40388.30405.15218.11-1,486.86
Consolidated Net Income3,975.903,953.20-535.603,619.603,322.002,342.102,711.651,176.812,086.60
Net Income From Continuing Operations3,975.903,953.20-535.603,619.603,322.002,342.102,711.651,176.812,096.39
Net Income3,975.903,953.20-535.603,619.603,322.002,342.102,711.651,176.812,096.39
EPS (Recurring)16.0716.8410.4815.1813.449.019.914.188.16
EPS (Basic, Before Extraordinaries)15.6615.46-2.0814.0512.979.0910.444.588.24
EPS (Diluted)15.5515.32-2.0813.8912.829.0110.294.518.09
EBITDA4,785.404,967.904,565.104,458.604,331.202,934.602,982.621,276.42737.64
Non-Operating Income (Expense)427.60455.90545.50625.20321.30-18.70156.66160.74-2.67
Other After Tax Adjustments0.000.000.000.000.000.000.000.00-0.50
Stock Option Compensation Expense529.30557.30446.90413.70347.20358.50282.50236.26190.09
Price To Earnings Ratio35.2435.24-30.5422.7924.3322.9748.6020.51
Price To Sales Ratio10.259.699.4510.778.557.5110.0313.8214.09
Gross Margin85.6185.0386.0787.1787.6588.1188.1486.7486.57
Operating Margin34.9439.4339.6943.4747.8136.9446.2728.3121.82
Net Margin30.5332.74-4.8836.7937.9730.8043.6728.4968.76
Shares Outstanding253.52253.99256.94257.70257.01254.48259.89258.99255.17
Market Capitalization138,910.93138,910.93103,706.93104,848.6474,127.2355,833.7461,457.3856,302.9942,348.52

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue3,439.003,344.103,012.403,227.103,115.402,986.002,746.102,887.50
Cost of Goods Sold Incl. D&A526.10489.20392.80466.00414.80407.50363.00423.40
Gross Profit2,912.902,854.902,619.602,761.102,700.602,578.502,383.102,464.10
Selling, General and Administrative Excl. Other2,105.801,576.001,455.301,460.701,422.801,403.001,376.101,376.30
Research and Development1,320.60993.80961.60973.70977.70978.40979.70998.70
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income807.101,278.901,164.301,300.401,277.801,175.501,007.001,087.80
Interest Expense36.00--3.303.303.703.002.80
Unusual Expense84.5043.70-6.0057.7077.00-0.20417.2066.10
Net Income Before Taxes783.401,391.801,252.901,331.001,298.801,283.00730.401,136.50
Income Taxes129.80292.00221.50139.90215.90250.1084.10223.50
Consolidated Net Income653.601,099.801,031.401,191.101,082.901,032.90646.30913.00
Net Income From Continuing Operations653.601,099.801,031.401,191.101,082.901,032.90646.30913.00
Net Income653.601,099.801,031.401,191.101,082.901,032.90646.30913.00
EPS (Recurring)2.794.434.014.814.413.993.623.68
EPS (Basic, Before Extraordinaries)2.584.334.064.694.244.022.523.55
EPS (Diluted)2.564.314.024.654.203.992.493.50
EBITDA876.301,335.401,220.201,353.501,331.801,227.201,055.401,132.90
Non-Operating Income (Expense)96.80156.6082.6091.60101.30111.00143.60117.60
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense138.80134.90131.10124.50147.40103.3371.81132.56
Price To Earnings Ratio35.2429.4529.1231.9527.99---
Price To Sales Ratio10.259.989.279.628.6010.1211.399.55
Gross Margin84.7085.3786.9685.5686.6986.3586.7885.34
Operating Margin23.4738.2438.6540.3041.0239.3736.6737.67
Net Margin19.0132.8934.2436.9134.7634.5923.5431.62
Shares Outstanding253.52253.35254.16253.99253.95256.29256.97256.94
Market Capitalization138,910.93126,072.56113,436.34115,026.05100,412.97114,326.02124,496.93103,706.93

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6,611.106,118.5011,221.5010,786.507,530.006,659.563,816.303,168.242,090.16
Short Term Receivables2,052.801,609.401,563.401,442.201,136.80885.35633.52414.87346.65
Inventories1,686.801,205.40738.80460.60353.10280.78167.50124.36111.83
Other Current Assets850.30663.10620.50545.50540.70307.69205.51135.64100.33
Total Current Assets11,201.009,596.4014,144.2013,234.809,560.608,133.384,822.833,843.112,648.96
Net Property, Plant & Equipment3,083.002,584.601,452.901,455.801,424.401,284.10833.28812.00789.44
Total Investments and Advances5,806.505,185.102,596.4099.4085.8020.8044.160.0020.45
Intangible Assets1,512.201,913.901,927.901,691.601,402.201,402.161,402.1650.3879.38
Deferred Tax Assets3,397.702,888.502,168.201,246.90934.50882.781,190.821,499.67-
Other Assets1,142.40922.10796.70422.4025.0028.5925.2340.737.78
Total Assets26,142.8023,090.6023,086.3018,150.9013,432.5011,751.818,318.476,245.903,546.01
Short Term Debt Incl. Current Port. of LT Debt82.8092.3083.7089.4080.2052.9550.309.8222.53
Accounts Payable461.70413.00364.90303.90195.00155.1487.61110.9973.99
Other Current Liabilities3,316.703,059.303,098.802,348.801,866.801,669.441,196.92999.49710.74
Total Current Liabilities3,861.203,564.603,547.402,742.102,142.001,877.531,334.831,120.29807.26
Long Term Debt1,953.201,657.20724.70810.30887.20889.50622.87581.55583.90
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities1,305.701,193.10924.10-----6.34
Other Liabilities356.90266.10309.70685.80303.30297.95275.53108.85106.20
Total Liabilities7,477.006,681.005,505.904,238.203,332.503,064.992,233.221,810.691,503.71
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity18,665.8016,409.6017,580.4013,912.7010,100.008,686.826,085.244,435.202,028.58
Total Shareholders Equity18,665.8016,409.6017,580.4013,912.7010,100.008,686.826,085.244,435.202,028.58
Accumulated Minority Interest0.000.000.000.000.000.000.000.0013.73
Total Equity18,665.8016,409.6017,580.4013,912.7010,100.008,686.826,085.244,435.202,042.31
Total Liabilities & Stockholders Equity26,142.8023,090.6023,086.3018,150.9013,432.5011,751.818,318.476,245.903,546.01
Book Value Per Share73.4963.8768.2254.1339.6933.4223.5017.388.01
Tangible Book Value Per Share67.5456.4260.7447.5534.1828.0318.0817.187.70
Full-Time Employees6,4006,1005,4004,8003,9003,4003,0002,5002,300
Price to Book Ratio6.646.646.355.695.537.079.329.5321.14
Return on Assets16.06-2.3217.5621.0418.6027.0216.1642.828.17
Return on Equity22.54-3.1522.9927.6724.9336.7122.3764.8716.53
Return on Invested Capital19.17-2.9619.7722.5621.3228.3217.5441.7910.07
Quick Ratio2.462.353.784.664.304.183.493.323.14
Current Ratio2.902.693.994.834.464.333.613.433.28

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income3,975.903,953.20-535.603,619.603,322.002,342.102,711.651,176.812,105.69
Depreciation237.30209.80207.20169.50148.30125.60109.52106.9472.42
Other Funds (Non Cash)729.201,178.30699.40550.40594.70435.60209.46184.29366.48
Funds from Operations4,653.204,830.5022.203,803.003,789.102,748.703,307.961,635.431,032.27
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-958.60-1,199.10-514.80-265.70340.80-105.20-54.45-66.10238.02
Cash from Operating Activities3,694.603,631.40-492.603,537.304,129.902,643.503,253.511,569.331,270.29
Capital Expenditures-492.30-437.60-485.40-258.40-204.70-235.00-259.80-75.45-95.52
Net Assets From Acquisitions-9,063.000.000.000.00-295.900.000.00-1,154.210.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments2,631.10-483.10-3,230.60-2,883.30179.50-105.90359.19-5.65-83.81
Purchase of Investments-7,192.40-6,396.50-7,696.20-3,817.50-740.50-605.20-450.72-576.51-515.39
Sale Or Maturity of Investments9,823.505,913.404,465.60934.20920.00499.30809.91570.86431.58
Other Uses-17.70-24.70-54.000.000.000.000.000.00-15.00
Other Sources75.500.000.000.000.000.000.000.000.07
Cash from Investing Activities-6,866.40-945.40-3,770.00-3,141.70-321.10-340.9099.39-1,235.32-194.26
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-909.90-1,889.70-1,062.50-293.00186.30-1,323.40-274.19151.23-60.75
Repurchase of Common Pref Stock-1,061.50-2,017.40-1,177.10-427.600.00-1,425.40-539.14-192.01-350.04
Sale of Common Pref Stock151.60127.70114.60134.60186.30102.00264.95343.24289.29
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net4,495.40-5.40-33.60-44.90-85.50-24.40-29.02-29.14-12.55
Change in Long Term Debt4,495.40-5.40-33.60-44.90-85.50-24.40-29.02-29.14-12.55
Issuance of Long Term Debt4,496.800.000.000.000.0022.6013.2510.0520.84
Reduction of Long Term Debt-1.40-5.40-33.60-44.90-85.50-47.00-42.27-39.19-33.39
Net Financing Active Other Cash Flow-331.30-366.20-398.80-224.30-168.50-130.20-202.074.682.08
Other Financing Activities Uses-332.40-369.90-405.00-226.10-172.00-135.90-202.07-7.82-5.42
Cash from Financing Activities3,254.20-2,261.30-1,494.90-562.20-67.70-1,478.00-505.28126.77-71.22
Exchange Rate Effect-41.6090.90-42.6026.90-29.20-13.4020.551.64-6.18
Net Change in Cash40.80515.60-5,800.10-139.703,711.90811.202,868.16462.43998.62
Free Cash Flow3,202.303,193.80-790.303,336.903,925.202,408.502,993.711,493.881,174.76
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow41.6636.62-31.7619.0623.7020.7938.2136.56
Deferred Taxes & Investment Tax Credit--510.80-348.80-536.50-275.90-154.60277.34167.39-1,512.33

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments6,312.607,863.007,258.706,611.106,295.206,392.60
Short Term Receivables2,311.002,134.301,996.102,052.801,946.401,893.50
Inventories2,245.301,765.101,766.701,686.801,626.801,499.30
Other Current Assets817.40781.30708.80850.30701.20642.50
Total Current Assets11,686.3012,543.7011,730.3011,201.0010,569.6010,427.90
Net Property, Plant & Equipment3,328.703,327.903,293.503,083.003,016.902,648.90
Total Investments and Advances3,562.905,829.005,789.305,806.505,732.205,645.90
Intangible Assets10,941.201,500.801,506.501,512.201,517.801,523.50
Deferred Tax Assets1,952.903,010.902,947.803,397.702,937.202,711.70
Other Assets1,264.301,211.001,217.001,142.401,088.601,078.80
Total Assets32,736.3027,423.3026,484.4026,142.8024,862.3024,036.70
Short Term Debt Incl. Current Port. of LT Debt999.600.000.0082.800.000.00
Accounts Payable472.60429.50489.30461.70420.30442.30
Other Current Liabilities3,528.103,508.403,391.303,316.704,055.003,696.10
Total Current Liabilities5,000.303,937.903,880.603,861.204,475.304,138.40
Long Term Debt5,478.801,977.601,986.501,953.201,834.801,527.40
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---1,305.70--
Other Liabilities1,349.801,259.901,255.40356.901,233.401,195.50
Total Liabilities11,828.907,175.407,122.507,477.007,543.506,861.30
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity20,907.4020,247.9019,361.9018,665.8017,318.8017,175.40
Total Shareholders Equity20,907.4020,247.9019,361.9018,665.8017,318.8017,175.40
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity20,907.4020,247.9019,361.9018,665.8017,318.8017,175.40
Total Liabilities & Stockholders Equity32,736.3027,423.3026,484.4026,142.8024,862.3024,036.70
Book Value Per Share82.4779.9276.1873.4968.2067.01
Tangible Book Value Per Share39.3174.0070.2567.5462.2261.07
Full-Time Employees---6,400--
Price to Book Ratio6.646.526.086.655.846.93
Return on Assets13.8117.1217.5816.0615.6016.47
Return on Equity20.8023.5424.2022.5422.3122.77
Return on Invested Capital2.484.954.835.785.655.52
Quick Ratio1.892.742.572.462.002.16
Current Ratio2.343.193.022.902.362.52

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income653.601,099.801,031.401,191.101,082.901,032.90
Depreciation69.2056.5055.9055.7054.0051.70
Other Funds (Non Cash)245.50153.80161.40168.50190.80234.70
Funds from Operations783.601,240.401,183.401,445.801,091.801,205.50
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-140.50-115.00244.70-947.80149.60-132.40
Cash from Operating Activities643.101,125.401,428.10498.001,241.401,073.10
Capital Expenditures-97.30-112.20-133.40-149.40-101.80-145.70
Net Assets From Acquisitions-9,063.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments3,059.80-7.40-298.50-122.80-16.00-334.50
Purchase of Investments-1,097.70-2,356.50-2,507.60-1,230.60-1,345.30-2,173.20
Sale Or Maturity of Investments4,157.502,349.102,209.101,107.801,329.301,838.70
Other Uses-0.10-1.700.00-15.900.80-4.30
Other Sources0.0075.500.000.000.000.00
Cash from Investing Activities-6,100.60-45.80-431.90-288.10-117.00-484.50
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-103.80-421.80-309.90-74.40-1,063.20-342.70
Repurchase of Common Pref Stock-126.70-469.50-336.90-128.40-1,071.10-391.80
Sale of Common Pref Stock22.9047.7027.0054.007.9049.10
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net4,496.800.000.00-1.40-1.40-1.30
Change in Long Term Debt4,496.800.000.00-1.40-1.40-1.30
Issuance of Long Term Debt4,496.800.000.000.000.000.00
Reduction of Long Term Debt0.000.000.00-1.40-1.40-1.30
Net Financing Active Other Cash Flow-96.10-4.90-228.90-1.40-89.90-5.20
Other Financing Activities Uses-96.10-4.90-228.90-2.50-91.00-5.90
Cash from Financing Activities4,296.90-426.70-538.80-77.20-1,154.50-349.20
Exchange Rate Effect-4.90-3.70-40.307.30-4.1057.20
Net Change in Cash-1,165.50649.20417.10140.00-34.20296.60
Free Cash Flow545.801,013.201,294.70348.601,139.60927.40
Price to Free Cash Flow41.6633.3930.8536.3530.2332.93

Revenue breakdown

ALYFTREK2025: 837.80M
Consolidation, Policy2025: 30.70M
Manufactured Product, Other2024: 781.50M 2025: 820.10M
TRIKAFTA/KAFTRIO2024: 10.24B 2025: 10.31B
Europe2024: 3.45B 2025: 3.46B
Other than United States and Europe2024: 881.30M 2025: 992.40M
United States2024: 6.68B 2025: 7.55B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.90%4.8M253.0M1.19M
2026-10-151.69%4.3M252.9M1.18M
2026-09-301.78%4.5M252.9M1.23M
2026-09-151.87%4.7M252.9M1.46M
2026-08-311.84%4.7M252.9M1.50M
2026-08-141.64%4.1M252.9M1.56M
2026-07-311.56%3.9M252.9M1.54M
2026-07-151.97%5.0M253.3M1.48M
2026-06-301.95%4.9M253.3M1.41M
2026-06-151.82%4.6M253.1M1.26M
2026-05-291.77%4.5M253.3M1.30M
2026-05-151.76%4.5M253.3M1.28M
2026-04-301.65%4.2M253.1M1.36M
2026-04-151.71%4.3M253.6M1.47M
2026-03-311.59%4.0M253.2M1.52M
2026-03-131.63%4.1M253.2M1.46M
2026-02-271.75%4.4M253.2M1.44M
2026-02-131.76%4.5M253.2M1.46M
2026-01-301.75%4.4M252.9M1.43M
2026-01-151.75%4.4M253.1M1.38M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call280253.4261.90.005.5700.000.000.993-0.7800.008
call290243.4251.90.005.2710.000.000.992-0.7760.009
call300233.5241.90.005.0230.000.000.992-0.7720.009
call310223.5231.30.004.6140.000.000.992-0.7670.009
call320213.5221.90.004.5860.000.000.991-0.7630.010
call325208.5216.90.004.3830.000.000.991-0.7600.010
call330203.5211.9208.654.3220.0020.000.991-0.7580.010
call335198.5206.3203.654.0580.0020.000.990-0.7550.010
call340193.5201.9198.654.0280.002.000.990-0.7520.011
call345188.5196.9193.653.9210.002.000.990-0.7490.011
call350183.5191.90.003.8850.000.000.989-0.7460.011
call355178.5186.90.003.7800.000.000.989-0.7430.012
call360173.5181.90.003.5610.000.000.989-0.7400.012
call365168.5176.90.003.6040.000.000.989-0.7370.012
call370163.51720.003.4910.000.000.988-0.7340.012
call375158.5166.80.003.3060.000.000.988-0.7300.013
call380153.51620.003.1640.000.000.987-0.7260.013
call385148.5156.60.003.1090.000.000.987-0.7230.014
call390143.51520.003.0130.000.000.987-0.7190.014
call395138.5146.61632.8771.000.000.986-0.7150.014
call400133.51420.002.8970.000.000.986-0.7110.015
call405128.51370.002.8010.000.000.985-0.7060.015
call410123.51320.002.7060.000.000.985-0.7020.016
call415118.51270.002.6110.000.000.984-0.6970.016
call420113.51220.002.5180.000.000.983-0.6920.017
call425108.51170.002.4250.000.000.983-0.6870.017
call430103.5111.60.002.3880.000.000.982-0.6810.018
call43598.501070.002.2400.000.000.981-0.6750.019
call44093.501020.002.1490.000.000.980-0.6690.019
call44588.5097.00113.22.0571.000.000.979-0.6630.020
call45083.5092.000.001.9670.000.000.978-0.6560.021
call45578.5087.000.001.8760.000.000.977-0.6490.022
call46073.5082.0098.801.7861.000.000.976-0.6420.023
call46568.5077.0093.901.6961.000.000.883-3.3550.079
call47063.6071.600.001.6750.000.000.878-3.2900.082
call47558.6067.0083.401.5151.000.000.872-3.2110.085
call48053.6061.800.001.4020.000.000.865-3.1330.088
call482.551.1059.900.001.3570.000.000.861-3.0910.089
call48548.7057.400.001.3460.000.000.857-3.0480.091
call487.546.2055.000.001.3430.000.000.853-3.0080.093
call49043.8052.5030.721.2430.000.000.849-2.9520.095
call492.541.3049.500.001.1980.000.000.844-2.9010.097
call49538.9047.7024.201.1520.000.000.839-2.8490.099
call497.536.5045.000.001.1450.000.000.833-2.8170.101
call50034.1042.0039.701.1269.000.000.827-2.7850.103
call502.531.7040.000.001.0500.000.000.820-2.7070.106
call50529.3037.8024.671.0028.000.000.813-2.6480.109
call507.527.0035.000.001.0240.000.000.802-2.6530.112
call51025.4032.9023.380.89714.000.000.799-2.5110.114
call512.522.3030.600.000.8640.000.000.787-2.4560.117
call51520.6028.0039.800.8548.000.000.773-2.4320.122
call517.517.7026.000.000.8410.000.000.758-2.4050.126
call52016.3023.7016.930.7745.000.000.748-2.3030.129
call522.513.3022.000.000.8040.000.000.704-2.6400.140
call52512.4019.2047.350.7253.000.000.688-2.4810.143
call527.510.5017.300.000.7060.000.000.663-2.4070.148
call5308.9015.1017.400.66330.000.000.637-2.2840.152
call532.56.9013.4017.600.6491.000.000.603-2.1960.156
call5355.7012.0013.040.64820.000.000.559-2.3240.159
call537.54.7010.907.500.6852.001.000.523-2.5830.161
call5404.007.8014.680.5427.000.000.473-2.1560.161
call542.52.609.0012.700.6104.000.000.436-2.3500.159
call5452.107.206.400.63646.001.000.403-2.4270.156
call547.51.458.200.000.6950.000.000.376-2.5520.153
call5501.353.003.900.46169.000.000.304-1.9010.141
call552.50.557.709.500.5081.000.000.281-1.9530.136
call5550.457.605.000.55419.000.000.266-2.0590.133
call557.50.453.100.000.5980.000.000.246-2.0680.127
call5600.356.703.790.64039.003.000.233-2.1230.124
call562.50.106.904.450.6821.000.000.219-2.1510.119
call5650.156.803.310.72311.001.000.207-2.1750.116
call5700.056.602.420.80115.000.000.188-2.2310.109
call5750.051.901.250.75821.000.000.143-1.7900.091
call5800.004.901.100.82614.000.000.129-1.7810.085
call5850.004.900.620.89140.000.000.117-1.7650.080
call5900.004.900.550.95511.000.000.107-1.7440.075
call5950.004.900.751.01211.000.000.101-1.7600.071
call6000.004.900.151.06320.000.000.097-1.7850.070
call6050.004.903.401.1331.000.000.092-1.8420.067
call6100.004.903.841.17914.000.000.089-1.8580.065
call6150.004.900.601.25372.000.000.085-1.9160.063
call6200.004.900.001.3040.000.000.082-1.9460.061
call6250.004.900.001.3590.000.000.079-1.9760.060
call6300.004.900.251.40322.000.000.077-1.9880.059
call6350.004.900.001.4540.000.000.075-2.0160.058
call6400.004.900.001.5060.000.000.073-2.0430.056
call6450.004.900.001.5570.000.000.071-2.0690.055
call6500.004.900.001.6060.000.000.069-2.0920.054
call6550.004.900.001.6580.000.000.067-2.1170.053
call6600.000.350.891.58010.000.000.051-1.6080.042
call6650.004.900.001.6280.000.000.049-1.6160.041
call6700.004.900.001.6730.000.000.048-1.6310.041
call6750.004.900.001.6970.000.000.047-1.6390.040
call6800.004.900.001.4250.000.000.048-1.2200.048
call6850.004.900.001.4630.000.000.047-1.2310.047
call6900.004.900.001.8150.000.000.045-1.6740.039
call6950.004.900.001.5380.000.000.045-1.2510.045
call7000.004.900.001.5750.000.000.044-1.2610.045
put2800.004.900.003.3170.000.00-0.007-0.5550.009
put2900.004.900.003.1580.000.00-0.007-0.5510.010
put3000.004.900.003.0040.000.00-0.008-0.5470.010
put3100.004.900.002.8550.000.00-0.008-0.5430.011
put3200.004.900.002.7100.000.00-0.009-0.5390.011
put3250.004.900.002.6400.000.00-0.009-0.5370.011
put3300.004.900.002.5700.000.00-0.009-0.5350.012
put3350.004.900.002.5010.000.00-0.009-0.5330.012
put3400.004.900.002.4330.000.00-0.009-0.5300.012
put3450.004.900.002.3670.000.00-0.010-0.5280.013
put3500.004.900.002.3000.000.00-0.010-0.5250.013
put3550.004.900.002.2350.000.00-0.010-0.5230.013
put3600.004.900.002.1710.000.00-0.011-0.5200.013
put3650.004.900.002.1070.000.00-0.011-0.5180.014
put3700.004.900.002.0440.000.00-0.011-0.5150.014
put3750.004.900.001.9820.000.00-0.012-0.5120.014
put3800.004.900.201.9212.000.00-0.012-0.5090.015
put3850.004.900.001.8600.000.00-0.012-0.5060.015
put3900.004.900.001.7990.000.00-0.013-0.5030.016
put3950.004.900.001.7400.000.00-0.013-0.5000.016
put4000.004.902.401.68127.000.00-0.013-0.4970.017
put4050.004.900.061.6222.000.00-0.014-0.4930.017
put4100.004.900.111.5651.000.00-0.014-0.4900.018
put4150.004.900.001.5070.000.00-0.015-0.4860.018
put4200.004.900.001.4500.000.00-0.015-0.4820.019
put4250.004.900.001.3940.000.00-0.016-0.4780.019
put4300.004.901.771.4650.000.00-0.018-0.6300.018
put4350.004.900.001.3940.000.00-0.019-0.6230.019
put4400.004.903.101.3331.000.00-0.020-0.6200.019
put4450.004.900.001.2690.000.00-0.020-0.6140.020
put4500.004.901.891.2021.000.00-0.022-0.6060.021
put4550.004.900.451.13810.000.00-0.023-0.5990.022
put4600.000.400.231.8066.000.00-0.111-3.3320.077
put4650.004.903.021.7331.000.00-0.116-3.3040.079
put4700.004.903.501.6261.000.00-0.122-3.2150.082
put4750.004.901.351.5467.000.00-0.128-3.1630.085
put4800.004.901.501.45513.000.00-0.135-3.0840.088
put482.50.004.900.001.4090.000.00-0.138-3.0430.089
put4850.004.9013.021.3634.000.00-0.142-3.0010.091
put487.50.004.900.001.3180.000.00-0.147-2.9630.093
put4900.004.908.301.27238.000.00-0.149-2.8690.094
put492.50.004.404.001.2247.000.00-0.158-2.9050.098
put4950.004.901.001.18732.000.00-0.161-2.8500.099
put497.50.007.100.001.1330.000.00-0.168-2.8010.101
put5000.004.900.401.07688.000.00-0.175-2.7340.105
put502.50.006.501.101.03964.000.00-0.181-2.7090.107
put5050.054.900.550.98522.000.00-0.187-2.5920.109
put507.50.054.900.600.94466.000.00-0.196-2.5990.112
put5100.104.600.500.88966.000.00-0.206-2.5070.115
put512.50.056.900.000.8400.000.00-0.213-2.3990.117
put5150.154.900.950.79728.000.00-0.227-2.4190.122
put517.50.054.200.880.7479.000.00-0.244-2.4240.127
put5200.056.701.410.69616.000.00-0.252-2.2450.129
put522.50.057.201.590.64417.000.00-0.274-2.2510.135
put5250.106.902.270.69113.000.00-0.312-2.4230.143
put527.50.108.002.810.6332.000.00-0.337-2.3480.148
put5300.406.003.000.57219.001.00-0.363-2.2250.152
put532.52.955.703.500.5092.002.00-0.397-2.1370.156
put5352.657.304.250.5434.000.00-0.441-2.2650.159
put537.53.009.607.800.6123.000.00-0.482-2.4540.161
put5404.309.904.630.55010.000.00-0.527-2.0960.161
put542.55.7012.007.000.5931.000.00-0.564-2.2900.159
put5457.4014.100.000.6310.000.00-0.597-2.3670.156
put547.58.9016.109.600.6582.001.00-0.624-2.4910.153
put55010.8018.2012.190.63010.000.00-0.700-1.7410.141
put552.512.9020.408.900.6412.000.00-0.726-1.7590.135
put55514.9023.200.000.7340.000.00-0.738-1.9050.132
put557.516.9025.200.000.8070.000.00-0.754-2.0060.127
put56019.2027.7024.430.85516.000.00-0.767-2.0610.124
put562.522.0030.000.000.7350.000.00-0.793-1.8900.116
put56523.8032.300.000.9170.000.00-0.793-2.1120.116
put57028.6037.100.000.9880.000.00-0.812-2.1670.109
put57533.5042.000.001.0620.000.00-0.857-1.7260.091
put58038.4046.900.001.1500.000.00-0.869-1.7300.086
put58543.3051.800.001.2280.000.00-0.881-1.7120.080
put59048.3056.700.001.2670.000.00-0.893-1.6790.075
put59553.9061.800.001.3490.000.00-0.899-1.6980.071
put60058.3066.800.001.3800.000.00-0.904-1.7360.069
put60563.3071.800.001.4890.000.00-0.908-1.7780.067
put61068.3076.800.001.5570.000.00-0.912-1.8140.065
put61573.3081.800.001.6230.000.00-0.915-1.8480.063
put62078.3086.800.001.6880.000.00-0.918-1.8800.061
put62583.3091.800.001.7420.000.00-0.921-1.9080.060
put63088.3096.800.001.8140.000.00-0.923-1.9390.058
put63593.30101.80.001.8760.000.00-0.925-1.9670.057
put64098.20106.80.001.9360.000.00-0.928-1.9930.056
put645103.2111.80.001.9950.000.00-0.930-2.0180.055
put650108.5116.80.002.0540.000.00-0.931-2.0430.053
put655113.2121.80.002.1110.000.00-0.933-2.0660.052
put660118.2126.80.002.1680.000.00-0.981-0.5130.019
put665123.2131.80.002.2230.000.00-0.981-0.5170.018
put670128.2136.80.002.2780.000.00-0.982-0.5210.018
put675133.6141.80.002.3320.000.00-0.982-0.5250.018
put680138.2146.80.002.3860.000.00-0.983-0.5290.017
put685143.4151.80.002.4380.000.00-0.983-0.5320.017
put690148.8156.60.002.4540.000.00-0.983-0.5350.017
put695153.6161.80.002.5420.000.00-0.984-0.5390.016
put700158.2166.80.002.5920.000.00-0.984-0.5420.016

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-06144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-028-KCurrent report2026-11-02SEC
2026-10-224Statement of changes in beneficial ownership of securities2026-10-20SEC
2026-10-223Initial statement of beneficial ownership of securities2026-10-20SEC
2026-10-208-KCurrent report2026-10-20SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-103Initial statement of beneficial ownership of securities2026-09-08SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-09-018-KCurrent report2026-08-27SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-27144Filing for proposed sale of securities under Rule 144.SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-07-234Statement of changes in beneficial ownership of securities2026-07-21SEC
2026-07-234Statement of changes in beneficial ownership of securities2026-07-21SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-074Statement of changes in beneficial ownership of securities2026-07-02SEC
2026-07-074Statement of changes in beneficial ownership of securities2026-07-02SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-02144Filing for proposed sale of securities under Rule 144.SEC
2026-07-02144Filing for proposed sale of securities under Rule 144.SEC
2026-07-01144Filing for proposed sale of securities under Rule 144.SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-26144Filing for proposed sale of securities under Rule 144.SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11006.31M1
2026-100000
2026-090000
2026-080000
2026-07002.00M3
2026-06003.74M5
2026-05005.27M6
2026-0400439.29K1
2026-03005.09M5
2026-020064.44M29
2026-01006.53M2
2025-120037.22M4
2025-110033.38M3

Institutional holders

Manager% owned
Capital World Investors10.29%
BlackRock, Inc.9.50%
Capital Research Global Investors7.68%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP4.68%
Invesco Ltd.3.17%
JPMORGAN CHASE & CO2.57%
GEODE CAPITAL MANAGEMENT, LLC2.40%
VANGUARD PORTFOLIO MANAGEMENT LLC1.92%
Capital International Investors1.85%

Funds

Fund% owned
Growth Fund of America5.09%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
Investment Co of America2.47%
American Balanced Fund2.19%
Invesco QQQ Trust, Series 12.12%
AMCAP Fund1.87%
iShares Core S&P 500 ETF1.38%
New Perspective Fund1.33%
Fidelity 500 Index Fund1.30%

OakChart. VRTX. Cached 15 minutes.